Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation

被引:16
作者
Brown, AL [1 ]
Peters, M [1 ]
D'Andrea, RJ [1 ]
Gonda, TJ [1 ]
机构
[1] Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5000, Australia
关键词
D O I
10.1182/blood-2003-05-1435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activation of the granulocyte-macrophage colony-stimulating factor (GM-CSF) family of receptors promotes the survival, proliferation, and differentiation of cells of the myeloid compartment. Several signaling pathways are activated downstream of the receptor, however it is not clear how these induce specific biologic outcomes. We have previously identified 2 classes of constitutively active mutants of the shared signaling subunit, human (h) betac, of the human GM-CSF/interieukin-3 (IL-3)/IL-5 receptors that exhibit different modes of signaling. In a factor-dependent bipotential myeloid cell line, FDB1, an activated mutant containing a substitution in the transmembrane domain (V449E) induces factor-independent proliferation and survival, while mutants in the extracellular domain induce factor-independent granulocyte-macrophage differentiation. Here we have used further mutational analysis to demonstrate that there are nonredundant functions for several regions of the cytoplasmic domain with regard to mediating proliferation, viability, and differentiation, which have not been revealed by previous studies with the wild-type GM-CSF receptor. This unique lack of redundancy has revealed an association of a conserved membrane-proximal region with viability signaling and a critical but distinct role for tyrosine 577 in the activities of each class of mutant.
引用
收藏
页码:507 / 516
页数:10
相关论文
共 37 条
[1]   Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3 [J].
Chin, H ;
Nakamura, N ;
Kamiyama, R ;
Miyasaka, N ;
Ihle, JN ;
Miura, O .
BLOOD, 1996, 88 (12) :4415-4425
[2]   A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors:: Insights from activated mutants of the common β subunit [J].
D'Andrea, RJ ;
Gonda, TJ .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (03) :231-243
[3]   MUTATION OF THE COMMON RECEPTOR SUBUNIT FOR INTERLEUKIN-3 (IL-3), GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND IL-5 THAT LEADS TO LIGAND INDEPENDENCE AND TUMORIGENICITY [J].
DANDREA, R ;
RAYNER, J ;
MORETTI, P ;
LOPEZ, A ;
GOODALL, GJ ;
GONDA, TJ ;
VADAS, M .
BLOOD, 1994, 83 (10) :2802-2808
[4]   Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family [J].
de Groot, RP ;
Coffer, PJ ;
Koenderman, L .
CELLULAR SIGNALLING, 1998, 10 (09) :619-628
[5]   Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor [J].
Dijkers, PF ;
van Dijk, TB ;
de Groot, RP ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
Coffer, PJ .
ONCOGENE, 1999, 18 (22) :3334-3342
[6]  
Durstin M, 1996, J IMMUNOL, V157, P534
[7]   Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors [J].
Evans, CA ;
Ariffin, S ;
Pierce, A ;
Whetton, AD .
BLOOD, 2002, 100 (09) :3164-3174
[8]   Activation of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development [J].
Evans, CA ;
Pierce, A ;
Winter, SA ;
Spooncer, E ;
Heyworth, CM ;
Whetton, AD .
BLOOD, 1999, 94 (05) :1504-1514
[9]   Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family [J].
Geijsen, N ;
Koenderman, L ;
Coffer, PJ .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (01) :19-25
[10]   Activating mutations in cytokine receptors: Implications for receptor function and role in disease [J].
Gonda, TJ ;
DAndrea, RJ .
BLOOD, 1997, 89 (02) :355-369